In the last 2 days I have made a reallocation. I have sold the well performing $VIG (+2,26%) and sold it and $UQA (+0,54%) into the portfolio. In my opinion, it offers more upside potential and also has a higher dividend yield.

I bought in December and sold my entire position today. It has done very well in the meantime, but I think we have pretty much reached the end of the line for now. I still took the dividend.

In general, I don't want to have any more shares in my portfolio where I have increased withholding tax expenses.

A new addition to the savings plan portfolio. $VIG (+2,26%) was kicked out today and replaced more or less 1:1 by MetLife. Even if the P/E ratio of 16 is of course already high compared to VIG at 6. Strangely enough, the share is actually significantly worse than VIG in terms of the figures (VIG 30% ratio yields 4.2%, Met 42% yields 2.4%), but higher dividend growth, higher new customer acquisition, higher profit/sales growth and, for me, the most important thing. There is enough cash flow available. While VIG's debt is growing, Met's equity is growing, which leads to share buybacks and dividend increases. I hope that I have analyzed better this time than last time 😉

Once again a position has been removed from the savings plan portfolio. It has fallen below all support lines and has been moving sideways for a long time, so the supports are all close together. The turnaround could work, but I don't see any positive news at the moment that could support it. But the loss is still limited for me. In addition, the company has not managed to increase its cash flow, which is now almost 500m in the red. It doesn't help that the dividend is over 4% as long as new debt has to be taken on. All in all, not a brilliant analyst performance on my part. I was too fooled by the positive environment in the insurance sector and simply valued VIG too highly.